MOBILion Systems, Inc.

Did you know that traditional MS/MS systems use as little as 0.5% of available ion signal? Our groundbreaking Parallel Accumulation with Mobility Aligned Fragmentation (PAMAF) method achieves near 100% ion utilization efficiency, offering an order of magnitude improvement in sensitivity. This leap forward allows for the detection of analytes at lower concentrations, providing deeper insights into complex samples. Learn how this enhanced sensitivity could revolutionize your research: https://lnkd.in/eyXxY7Qb #MOBILionInnovates #MassSpec #Sensitivity #Metabolomics #AnalyticalChemistry #ScientificInnovation

How are labs adapting to rising #PFAS concerns? Our SVP of Global Business, Frederick Strathmann, Ph.D., joins experts from the EPA, Million Marker, Eurofins, and NMS Labs in Clinical Chemistry to discuss the critical questions surrounding PFAS testing and analysis. From regulatory compliance to patient care, discover how advanced analytical technologies are transforming our ability to detect, quantify, and understand these persistent compounds. These experts explore why traditional testing methods fall short and how innovations in laboratory medicine are helping protect public health. Find the article in Clinical Chemistry here: https://lnkd.in/euihyU2B #EnvironmentalHealth #PFAS #ClinicalChemistry #AnalyticalScience

Did you know thousands of PFAS compounds exist, but traditional testing methods detect only a fraction? Hear from experts from the EPA, Million Marker, Eurofins, and NMS Labs as they explore how next-generation analytical technologies are revolutionizing our approach to PFAS detection and monitoring in a new Clinical Chemistry Q&A article. Learn how these advances are helping laboratories deliver more comprehensive PFAS analyses: https://hubs.ly/Q02YTvlV0 #PFAS #EnvironmentalTesting #ClinicalChemistry #AnalyticalInnovation

We’re honored to welcome Steven Carr, Ashok Dongre,  Alexey Nesvizhskii, Benjamin Orsburn, Birgit Schilling, Nikolai Slavov, and John Yates as members of our inaugural Proteomics Advisory Board! Following our successful kickoff meeting, we're already advancing plans to experimentally validate our breakthrough PAMAF technology. These six distinguished leaders bring decades of pioneering expertise in mass spectrometry, bioinformatics, and protein analysis, with more than 1,500 peer-reviewed publications collectively. Together, we're making rapid progress toward realizing PAMAF's potential across critical applications - from advancing single-cell proteomics to enhancing biomarker discovery. This marks an exciting chapter in our mission to reveal what others leave unseen. Learn more: https://lnkd.in/eUG4ebbT #Proteomics #Innovation #MassSpectrometry #RevealTheUnseen

Our CEO Melissa Sherman, Ph.D., spoke with GenomeWeb about how our new PAMAF approach can transform #proteomics research. By removing the quadrupole, this technology could allow scientists to conduct mass spec-based proteomics with improved speed and sensitivity.   Learn more about our approach and how it’s a paradigm shift for proteomics and beyond: https://lnkd.in/eSssz65c #MassSpectrometry #Innovation #AnalyticalScience #Proteomics #ResearchAndDevelopment

The hidden complexity of PFAS detection has long challenged environmental scientists. Traditional analysis methods often miss critical compounds while consuming hours of valuable lab time. Join us at the Eastern Analytical Symposium to discover what our MOBIE system can do. Our presentation 'Forensic Fingerprinting of the Unseen: Revealing the Dark Secrets of PFAS with High-Resolution Ion Mobility' demonstrates how we're transforming environmental analysis from a time-intensive challenge into a precise, efficient process. https://lnkd.in/eRqXiepw #EnvironmentalScience #PFAS #AnalyticalChemistry  Frederick Strathmann

What if you could see the complete PFAS story in every sample? Traditional methods often leave critical compounds hidden, creating blind spots in environmental analysis. At the Eastern Analytical Symposium next week, we're showcasing how MOBIE can illuminate these blind spots. Our presentation will discuss how we are transforming PFAS detection, enabling scientists to identify and quantify previously undetectable compounds with unprecedented speed and precision. https://hubs.ly/Q02YpgX40 #RevealTheUnseen #EnvironmentalScience #AnalyticalInnovation #PFAS Fredrick Strathmann

Mobility Aligned Fragmentation (MAF) represents the evolution of Parallel CID, a concept first explored over 20 years ago. Now, with the advanced capabilities of SLIM technology, we've unlocked the full potential of this approach. Dive into our white paper to explore the history and future of this game-changing approach to complex sample analysis, and see how PAMAF is poised to become as ubiquitous as the quadrupole: https://hubs.ly/Q02YfCHs0 #MOBILionInnovates #AnalyticalChemistry #ResearchAndDevelopment #LifeSciences

Check out the exciting developments in research using MOBILion's SLIM technology and the researchers pioneering this work featured in the latest issue of the Journal of the American Society for Mass Spectrometry! ACS Publications We’re thrilled to spotlight three new articles where MOBILion's MOBIE high resolution IM system is driving advancements in critical research areas: 1️ - "High Resolution Ion Mobility Enables the Structural Characterization of Atropisomers of GDC-6036, a KRAS G12C Covalent Inhibitor" – The team at Genentech demonstrates using HRIM to analyze challenging atropisomers for an investigational oncology treatment.  2️ - "Leveraging High-Resolution Ion Mobility-Mass Spectrometry for Cyclic Peptide Soft Spot Identification" – The team at Merck employs HRIM to identify vulnerable metabolic sites of cyclic peptides with greater precision.  3️ - "SLIM-Based High-Resolution Ion Mobility Reveals New Structural Insights into Isomeric Vitamin D Metabolites and their Isotopologues" – The team at Clemson University is pushing the boundaries of nutrition and health using HRIM for improved monitoring of Vitamin D metabolic pathways. Also, congratulations to Chris M. Crittenden, Christopher Chouinard, Ahmed Hamid, Komal Kedia, Ph.D., and Aivett Bilbao who were honored as 2024 Emerging Investigators. Thank you to these trailblazers for their dedication to advancing SLIM technology!  Read more about this amazing research and these researchers here: https://lnkd.in/eWQZYGbR #MassSpectrometry #SLIM #KRAS #DrugDiscovery #VitaminDResearch #MOBILionSystems #ScientificBreakthroughs #ThankYouResearchers #JASMS 

Cyclic peptides offer immense potential for targeting previously undruggable proteins, but their complex structures present unique analytical challenges. Traditional methods of cyclic peptide analysis miss critical soft spots that can derail drug development. Our MOBIE system enables researchers to precisely identify soft spots prone to enzymatic degradation, accelerating the path from bench to bedside. Join us on November 12th for a webinar featuring Komal Kedia, Ph.D., Associate Principal Scientist at Merck. She will explore how our MOBIE technology is transforming drug development through advanced cyclic peptide characterization, delivering faster analysis with superior resolution. Register now: https://hubs.ly/Q02X9L950 #DrugDiscovery #BiopharmaInnovation #MassSpectrometry #CyclicPeptides